Hematolymphoid malignancies diagnosed at the time of radical prostatectomy

Martha Kennedy Terris, John Hausdorff, Fuad S. Freiha

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Purpose: The clinical impact of hematolymphoid malignancies discovered during radical prostatectomy has not been previously defined to our knowledge. Materials and Methods: From October 1988 to September 1995, 1,092 patients underwent radical retropubic prostatectomy. Results: Of 1,092 radical prostatectomy specimens, 13 (1.2%) were found to have hematologic malignancies involving the prostate and/or lymph nodes sampled during concomitant pelvic lymph node dissection. The malignancies detected included Hodgkin's disease (3) and hairy cell leukemia (1), which required further therapy. However, 9 of the 13 patients (62%) demonstrated either chronic lymphocytic leukemia (3) or low grade, small lymphocytic lymphoma (6), which requires symptomatic treatment only. The transrectal ultrasound guided prostate biopsies revealed suspicious lymphocytic infiltrate in addition to prostatic adenocarcinoma in 2 of the 13 patients (15%). Conclusions: The majority of hematologic malignancies discovered at radical prostatectomy do not require further treatment and should not delay treatment of prostatic adenocarcinoma.

Original languageEnglish (US)
Pages (from-to)1457-1459
Number of pages3
JournalJournal of Urology
Volume158
Issue number4
DOIs
StatePublished - Jan 1 1997
Externally publishedYes

Fingerprint

Prostatectomy
Hematologic Neoplasms
B-Cell Chronic Lymphocytic Leukemia
Prostate
Neoplasms
Adenocarcinoma
Hairy Cell Leukemia
Therapeutics
Lymph Node Excision
Hodgkin Disease
Lymph Nodes
Biopsy

Keywords

  • Leukemia
  • Lymphoma
  • Prostatic neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Hematolymphoid malignancies diagnosed at the time of radical prostatectomy. / Terris, Martha Kennedy; Hausdorff, John; Freiha, Fuad S.

In: Journal of Urology, Vol. 158, No. 4, 01.01.1997, p. 1457-1459.

Research output: Contribution to journalArticle

Terris, Martha Kennedy ; Hausdorff, John ; Freiha, Fuad S. / Hematolymphoid malignancies diagnosed at the time of radical prostatectomy. In: Journal of Urology. 1997 ; Vol. 158, No. 4. pp. 1457-1459.
@article{007b4c34b3b7492498f38a57e628538d,
title = "Hematolymphoid malignancies diagnosed at the time of radical prostatectomy",
abstract = "Purpose: The clinical impact of hematolymphoid malignancies discovered during radical prostatectomy has not been previously defined to our knowledge. Materials and Methods: From October 1988 to September 1995, 1,092 patients underwent radical retropubic prostatectomy. Results: Of 1,092 radical prostatectomy specimens, 13 (1.2{\%}) were found to have hematologic malignancies involving the prostate and/or lymph nodes sampled during concomitant pelvic lymph node dissection. The malignancies detected included Hodgkin's disease (3) and hairy cell leukemia (1), which required further therapy. However, 9 of the 13 patients (62{\%}) demonstrated either chronic lymphocytic leukemia (3) or low grade, small lymphocytic lymphoma (6), which requires symptomatic treatment only. The transrectal ultrasound guided prostate biopsies revealed suspicious lymphocytic infiltrate in addition to prostatic adenocarcinoma in 2 of the 13 patients (15{\%}). Conclusions: The majority of hematologic malignancies discovered at radical prostatectomy do not require further treatment and should not delay treatment of prostatic adenocarcinoma.",
keywords = "Leukemia, Lymphoma, Prostatic neoplasms",
author = "Terris, {Martha Kennedy} and John Hausdorff and Freiha, {Fuad S.}",
year = "1997",
month = "1",
day = "1",
doi = "10.1016/S0022-5347(01)64242-3",
language = "English (US)",
volume = "158",
pages = "1457--1459",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Hematolymphoid malignancies diagnosed at the time of radical prostatectomy

AU - Terris, Martha Kennedy

AU - Hausdorff, John

AU - Freiha, Fuad S.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Purpose: The clinical impact of hematolymphoid malignancies discovered during radical prostatectomy has not been previously defined to our knowledge. Materials and Methods: From October 1988 to September 1995, 1,092 patients underwent radical retropubic prostatectomy. Results: Of 1,092 radical prostatectomy specimens, 13 (1.2%) were found to have hematologic malignancies involving the prostate and/or lymph nodes sampled during concomitant pelvic lymph node dissection. The malignancies detected included Hodgkin's disease (3) and hairy cell leukemia (1), which required further therapy. However, 9 of the 13 patients (62%) demonstrated either chronic lymphocytic leukemia (3) or low grade, small lymphocytic lymphoma (6), which requires symptomatic treatment only. The transrectal ultrasound guided prostate biopsies revealed suspicious lymphocytic infiltrate in addition to prostatic adenocarcinoma in 2 of the 13 patients (15%). Conclusions: The majority of hematologic malignancies discovered at radical prostatectomy do not require further treatment and should not delay treatment of prostatic adenocarcinoma.

AB - Purpose: The clinical impact of hematolymphoid malignancies discovered during radical prostatectomy has not been previously defined to our knowledge. Materials and Methods: From October 1988 to September 1995, 1,092 patients underwent radical retropubic prostatectomy. Results: Of 1,092 radical prostatectomy specimens, 13 (1.2%) were found to have hematologic malignancies involving the prostate and/or lymph nodes sampled during concomitant pelvic lymph node dissection. The malignancies detected included Hodgkin's disease (3) and hairy cell leukemia (1), which required further therapy. However, 9 of the 13 patients (62%) demonstrated either chronic lymphocytic leukemia (3) or low grade, small lymphocytic lymphoma (6), which requires symptomatic treatment only. The transrectal ultrasound guided prostate biopsies revealed suspicious lymphocytic infiltrate in addition to prostatic adenocarcinoma in 2 of the 13 patients (15%). Conclusions: The majority of hematologic malignancies discovered at radical prostatectomy do not require further treatment and should not delay treatment of prostatic adenocarcinoma.

KW - Leukemia

KW - Lymphoma

KW - Prostatic neoplasms

UR - http://www.scopus.com/inward/record.url?scp=0030880578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030880578&partnerID=8YFLogxK

U2 - 10.1016/S0022-5347(01)64242-3

DO - 10.1016/S0022-5347(01)64242-3

M3 - Article

VL - 158

SP - 1457

EP - 1459

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 4

ER -